R Martín-Vivaldi
- Pharmacology top 2%
- Hepatology top 5%
- Epidemiology
- Oncology
- Surgery
- Co-authors
- F. NoguerasGloria Isabel Carvajal PeláezRaúl J. AndradeM. Isabel LucenaLuı́s RodrigoJosé Antonio DuránJavier SalmerónJ.M. Navarro
- Topics
- Drug-Induced Hepatotoxicity and Protection (4 papers)Drug Transport and Resistance Mechanisms (3 papers)Liver Disease Diagnosis and Treatment (3 papers)
In The Last Decade
R Martín-Vivaldi
18 papers receiving 354 citations
Peers
Comparison fields: 5 of 58
- Pharmacology 192
- Hepatology 120
- Epidemiology 102
- Oncology 87
- Surgery 74
Countries citing papers authored by R Martín-Vivaldi
This map shows the geographic impact of R Martín-Vivaldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Martín-Vivaldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Martín-Vivaldi more than expected).
Fields of papers citing papers by R Martín-Vivaldi
This network shows the impact of papers produced by R Martín-Vivaldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Martín-Vivaldi. The network helps show where R Martín-Vivaldi may publish in the future.
Co-authorship network of co-authors of R Martín-Vivaldi
This figure shows the co-authorship network connecting the top 25 collaborators of R Martín-Vivaldi. A scholar is included among the top collaborators of R Martín-Vivaldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Martín-Vivaldi. R Martín-Vivaldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 24 | |
| 2 | 6 | |
| 3 | 37 | |
| 4 | 66 | |
| 5 | 27 | |
| 6 | 15 | |
| 7 | 108 | |
| 8 | Flutamide-induced hepatotoxicity: report of a case series. | 31 |
| 9 | Multicenter retrospective study of response to interferon in chronic hepatitis B. | 1 |
| 10 | 38 | |
| 11 | Response of chronic hepatitis C to interferon-alpha treatment and relationship with iron metabolism. | 5 |
| 12 | [Pasteurella multocida as a cause of spontaneous bacterial peritonitis in a cirrhotic patient]. | 1 |
| 13 | [Comparison of the indexes of serologic activity with endoscopy in intestinal inflammatory disease]. | 1 |
| 14 | [Intrahepatic cholestasis of pregnancy. Maternofetal implications]. | 3 |
| 15 | [Thyroid dysfunction in patients with chronic hepatitis C pre and post treatment with interferon]. | 3 |
| 16 | [Emergency laparoscopy. A 20-year experience]. | 4 |
| 17 | [Caroli's syndrome: a variable entity]. | 1 |
| 18 | [The effect of environmental factors in inflammatory bowel disease]. | 1 |
| 19 | [Ultrasonics in the diagnosis of primary and metastatic hepatic tumors]. | 0 |
About R Martín-Vivaldi
R Martín-Vivaldi is a scholar working on Hepatology, Transplantation and Pharmacology, having authored 19 papers that have together received 372 indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). The work is most often cited by research in Pharmacology (192 citations), Hepatology (120 citations) and Transplantation (38 citations). R Martín-Vivaldi has collaborated with scholars based in Spain and Nicaragua. Frequent co-authors include F. Nogueras, Gloria Isabel Carvajal Peláez, Raúl J. Andrade, M. Isabel Lucena, Luı́s Rodrigo, José Antonio Durán, Javier Salmerón, J.M. Navarro, Manuel Romero‐Gómez and Manuel Jesús Romero-Jiménez. Their work appears in journals such as Gastroenterology, Hepatology and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.